Bionexus gene lab corp. announces board approval of ethereum treasury strategy and release of strategic whitepaper

Kuala lumpur, malaysia, march 06, 2025 (globe newswire) -- bionexus gene lab corp. (nasdaq: bglc), a technology company dedicated to innovation in technology and healthcare, is pleased to announce that its board of directors has formally approved the company's new ethereum-focused treasury strategy. this decision marks bglc as the first nasdaq-listed company to exclusively prioritize ethereum (eth) as a strategic treasury asset, and is in line with recent announcements of ethereum being included in the us “crypto strategic reserve”.
BGLC Ratings Summary
BGLC Quant Ranking